Is Hydrogen Water Actually Good for You? Revisiting TIME’s Article With the 2026 Evidence
I originally wrote this article in 2020 as a rebuttal to TIME’s 2017 feature, “Is Hydrogen Water Actually Good For You?” At the time, I thought several parts of the article gave readers an incomplete picture of the molecular-hydrogen research. Six years later, I think the fairest way to update my own article is to reassess both sides.
My central criticism of the TIME article still stands. I do not think the 2017 feature represented the state of molecular-hydrogen research very well, even for that time. Challenging companies that were making claims beyond the available evidence was appropriate. The problem was that the article moved from “some commercial claims are not yet proven” to an overall impression that the underlying science was weak, sparse, or little more than a wellness fad.
That framing did not adequately reflect what the scientific literature and active hydrogen researchers were already saying. By 2015, a comprehensive review had identified 321 original molecular-hydrogen publications, noted that clinical trials were increasing every year, and summarized the more dependable human studies. Another 2015 clinical review described H2 as a novel medical gas within the clinical environment and reported improvements in clinical endpoints and surrogate markers in several trials while also emphasizing unresolved questions involving dosage, administration, pharmacology, and larger clinical validation. In 2016, researchers were already publishing reviews specifically examining hydrogen-rich water and its possibilities for clinical application.
The public message from researchers working in the field was similarly measured—not that hydrogen was a proven cure, but that the data were promising, therapeutically relevant, and deserving of more clinical research. Tyler LeBaron and the Molecular Hydrogen Institute were publicly presenting H2 as a therapeutic medical gas before TIME published its article, including medical and scientific presentations in 2015, 2016, and the first half of 2017. The research community was actively discussing clinical significance, mechanisms, dose, signaling, and the need for larger trials.
Some of TIME’s narrower cautions were valid. Disease-specific dosing was still being worked out, larger clinical studies were needed, mechanisms were not fully understood, and packaging really did matter because dissolved H2 can dissipate. But those unresolved questions were also being explicitly acknowledged by hydrogen researchers themselves. In my view, they did not justify presenting the field as if there were little meaningful human evidence or as if hydrogen water were simply the latest health fad.
H2HUBB Takeaway
- The human and clinical evidence was already more substantial in 2017 than TIME’s framing suggested. A 2015 comprehensive review had identified 321 original H2 publications, reported that clinical trials were increasing every year, and summarized dependable human studies. A separate 2015 clinical review described molecular hydrogen as an emerging novel medical gas and reported clinical endpoints and surrogate-marker improvements in several trials.
- The exercise literature shows a recurring pattern of benefit, even though not every pooled endpoint is significant. A 2024 physical-performance meta-analysis included 27 publications and found significant improvements in lower-limb explosive power, perceived exertion, and blood lactate. Its own subgroup analyses found especially large reductions in perceived exertion during strength training and repeated sprints, while individual randomized studies have also reported improvements in endurance, VO2 peak, repeated-sprint performance, power output, muscle function, heart-rate recovery, soreness, and recovery. The correct interpretation is not that H2 “does not improve exercise”; it is that the effect depends strongly on the outcome, athlete, route, dose, timing, and exercise model.
- The broader human evidence also supports therapeutic potential beyond exercise. Human systematic reviews and meta-analyses now report favorable effects in distinct clinical areas, including blood-lipid regulation, hepatic oxidative-stress markers, periodontal inflammation and oxidative stress, and exercise-related antioxidant capacity. These bodies of evidence should not be blended into one universal efficacy claim, but together they show that molecular hydrogen is producing measurable biological and clinical signals across multiple human populations.
- Active researchers were not describing hydrogen as a fad. Before and around the TIME article, researchers and educators in the field—including Tyler LeBaron—were publicly describing molecular hydrogen as a therapeutic or emerging medical gas with promising clinical significance while simultaneously calling for larger trials, clearer mechanisms, and better dose-response research.
- Direct human anti-inflammatory evidence exists. Randomized human work has reported changes in inflammatory signaling and cell-death measures after hydrogen-water consumption, although specific outcomes vary by population and protocol.
- Dose is no longer an unknowable concept, but there is no universal clinical dose. Human trials now report concentrations, water volumes, and milligrams of H2 more deliberately. Recent metabolic trials have ranged from roughly 3 mg/day to more than 12 mg/day, while H2HUBB’s product standards use practical minimum delivery thresholds rather than claiming a disease-specific prescription.
- TIME was right that packaging matters. Dissolved H2 can be lost during storage, which is why H2-retaining packaging and verified hydrogen content are important for ready-to-drink products.
- My 2026 position is more precise than my 2020 rebuttal. I think the evidence supports therapeutic potential and continued investigation, but I would not use inhalation studies to prove hydrogen-water outcomes, nor would I imply that one broad dose range is established for every person or condition.
What TIME Was Actually Responding To
Alice Park’s TIME article was published on August 21, 2017, when commercial hydrogen water was receiving more mainstream attention in the United States. I think it was entirely appropriate to question companies making claims about energy, workout recovery, inflammation, diabetes, cardiovascular disease, Alzheimer’s disease, cancer, or other health outcomes if those companies were presenting early findings as settled clinical fact.
Where I disagree is with the investigative framing of the science itself. TIME characterized the support behind the claims as mostly limited animal work and a few small human trials. That description did not give readers a fair picture of the body of molecular-hydrogen research or of how researchers in the field were interpreting the human evidence at the time.
Two years before the TIME article, a 2015 Medical Gas Research review had already catalogued 321 original molecular-hydrogen articles published from 2007 through June 2015 and stated that the number of clinical trials was increasing every year. The authors specifically summarized dependable clinical studies recruiting more than ten patients or using double-blind designs and concluded that large-scale controlled human studies and elucidation of molecular mechanisms were the next steps.
Also in 2015, a review in Annals of Medicine was not describing H2 as a fad. Its key message was that molecular hydrogen was emerging as a novel medical gas within the clinical environment. The review stated that H2 had improved clinical endpoints and surrogate markers in several trials, while identifying dosage, administration, pharmacology, adverse reactions, and special populations as major areas still requiring investigation. That is a very different scientific position from saying there was essentially no meaningful human evidence.
By 2016, an Okayama University review was specifically examining hydrogen-rich water and its possibilities for clinical application. Researchers were treating oral hydrogen water as one of the established administration routes used to deliver molecular H2, alongside inhalation and hydrogen-rich saline.
The same distinction was present in public scientific education. Tyler LeBaron had been presenting molecular hydrogen to medical and scientific audiences for years before the TIME article. His documented talks included “Molecular Hydrogen: therapeutic and medical applications” in 2015, “Hydrogen: A Small Molecule with Great Clinical Significance” in 2016, “Hydrogen: A Therapeutic Medical Gas” in March 2017, and “Hydrogen: signal modulator for disease and inflammation” in June 2017. MHI also documented a July 2017 discussion between LeBaron and pioneering researcher Dr. Shigeo Ohta on the therapeutic potential of hydrogen gas.
That does not mean hydrogen water had already been clinically proven for every claimed benefit. It means the more faithful representation of the field in 2017 was: promising human and preclinical evidence, an emerging therapeutic medical gas, common administration through hydrogen-rich water, important unanswered questions about primary mechanisms and dosing, and a clear need for larger controlled human trials.
That was the core point of my original rebuttal, and it remains my position today.
The Hydrogen-Water Literature Is Much Larger Than It Was in 2017
One of the clearest changes is simply the amount and organization of human evidence. A 2024 systematic review of hydrogen-rich water included 25 human publications after screening the literature and excluding animal studies. The review covered exercise, metabolic and cardiovascular outcomes, oxidative stress, inflammation, liver-related outcomes, mental health, and other areas, and described the clinical findings as encouraging while calling for larger and more rigorous studies.
Those numbers do not mean every publication is a positive human hydrogen-water trial. H2HUBB separates human, animal, laboratory, and review evidence for exactly that reason. But they do show why a 2017 description of the field cannot be treated as a current summary in 2026.
The Therapeutic-Potential Argument Is Bigger Than Any One Meta-Analysis
Another reason I do not think molecular hydrogen should be evaluated through one pooled result is that the human evidence is now spread across multiple physiological and clinical areas. Meta-analyses are valuable because they help us see the average effect within a defined question. But each review only captures the studies that fit that review’s eligibility criteria.
When we look across the human literature rather than asking one meta-analysis to represent the entire field, the pattern is broader. Molecular hydrogen has produced measurable effects in exercise physiology, metabolic health, lipid regulation, liver-related oxidative stress, inflammatory signaling, oral inflammatory disease, and other clinical settings.
Significant Improvements in Several Lipid Measures
A systematic review and meta-analysis of seven clinical studies found significant reductions in total cholesterol, LDL cholesterol, and triglycerides after hydrogen-rich-water consumption. The authors described the effects as small to moderate and concluded that HRW significantly improved several elements of blood-lipid status in the studied clinical populations.
Large Reduction in Malondialdehyde
A systematic review and meta-analysis included 12 studies published from 2008 through 2022. Molecular hydrogen significantly reduced serum malondialdehyde, with a large pooled effect, and the authors also reported a strong trend toward improvement in liver-function tests such as AST and ALT.
Inflammation, Oxidative Stress and Oral Flora
A systematic review and meta-analysis included 17 studies and 304 subjects with periodontal inflammatory conditions. The authors concluded that hydrogen-rich water inhibited inflammatory responses, oxidative stress, and bacterial proliferation activity compared with pure-water controls. The review also identified some risk-of-bias concerns, which should be considered when interpreting the strength of the findings.
Improved Biological Antioxidant Potential
A separate exercise systematic review and meta-analysis found a significant improvement in biological antioxidant potential with H2 supplementation. The effect was larger during intermittent exercise, while pooled d-ROM oxidative-stress levels did not significantly decrease.
This is the distinction I think the original TIME article missed. The responsible scientific position is not that every positive signal proves a treatment. It is that repeated human findings across different organ systems and clinical questions are evidence of therapeutic potential. Researchers can simultaneously recognize those signals and say that mechanisms, dose-response relationships, larger trials, and disease-specific clinical validation still need further work.
That is also why H2HUBB does not reduce the field to a single meta-analysis. We use systematic reviews to understand the pooled evidence, individual trials to understand protocol-specific responses, and the broader research landscape to understand where molecular hydrogen repeatedly shows biological activity in humans.
TIME Claim #1: Was the Science Behind Hydrogen Water “Weak”?
TIME described the evidence behind popular commercial claims as “the science behind those claims is weak.”
I disagree with using weak as the overall characterization of the science even in 2017. It was fair to say that specific commercial claims could exceed the available clinical evidence. That is not the same statement as saying the underlying research field was weak.
By the time TIME published its article, peer-reviewed reviews were already describing molecular hydrogen as an emerging or novel medical gas, reporting clinical endpoints and surrogate-marker improvements in human studies, documenting an increasing number of clinical trials, and identifying hydrogen-rich water as a common and practical route of H2 administration. Researchers were simultaneously saying that larger controlled trials, dose-response work, and clarification of the primary molecular mechanisms were still needed. In my view, that is the definition of a promising developing field, not a fad supported by little meaningful data.
The distinction matters: “not yet conclusively proven for a particular claim” does not equal “the science is weak.” A deeper investigation should have shown readers both sides of that scientific reality.
Commercial Claims Needed Scrutiny
A company should not turn promising early evidence into a claim that hydrogen water has already been proven to increase energy, prevent disease, or treat every condition connected to oxidative stress.
The Research Was More Developed Than the Article Conveyed
Contemporaneous reviews already discussed clinical studies, increasing clinical trials, therapeutic potential, and H2 as an emerging medical gas. The modern human evidence has since expanded across exercise, metabolic, hepatic, inflammatory, and other clinical areas, reinforcing why that scientific context mattered.
Promising Evidence and Unanswered Questions Can Both Be True
A scientifically responsible position can recognize therapeutic promise while still calling for larger trials, clearer mechanisms, and better dose-response research.
How I Would Make the Original Rebuttal More Precise Today
The core argument of my 2020 rebuttal remains the same: TIME underrepresented the scientific context and did not adequately communicate the therapeutic promise researchers were already discussing. What I would improve today is the evidence hierarchy.
Hydrogen inhalation, hydrogen-rich saline, hydrogen water, baths, and other delivery methods all expose the body to H2, but they are not interchangeable interventions. When I evaluate a claim specifically about hydrogen water, I now lead with hydrogen-water studies and then use the broader molecular-hydrogen literature for mechanism, biological plausibility, and supporting context.
That refinement makes the rebuttal stronger because it distinguishes what hydrogen-water studies directly showed from what the broader H2 field suggested about therapeutic potential.
What About Energy, Exercise Performance and Recovery?
This is one section where I think it is especially important not to let a pooled meta-analysis become the entire story.
The 2024 systematic review and meta-analysis on physical performance is important and should be included. It analyzed 27 publications involving 597 participants, including 373 trained participants and 215 well-trained athletes. Its pooled analysis found a significant improvement in lower-limb explosive power and significant reductions in rating of perceived exertion and blood lactate. The pooled effects for VO2max/VO2peak, overall aerobic endurance, 30-second anaerobic endurance, and maximal muscular strength did not reach statistical significance.
But that does not mean the literature shows that molecular hydrogen has no meaningful effect on endurance, aerobic capacity, anaerobic performance, or muscle function. The meta-analysis itself makes that distinction. Three of the included studies individually reported significant improvements in VO2max or VO2peak, two reported significant improvements in aerobic exercise performance, and several studies reported positive effects on power, sprint performance, fatigue, lactate, or recovery. Pooling different populations, doses, administration routes, exercise tests, and intervention durations answers the question, “What is the average effect across these eligible studies?” It does not erase a significant response demonstrated under a specific protocol.
Why a Meta-Analysis Does Not Represent the Entire Athlete Literature
The 2024 physical-performance meta-analysis had deliberately narrow inclusion rules. Studies had to involve healthy adults with a mean age of at least 18, use a randomized controlled or randomized crossover design, provide a matched placebo, and report a qualifying physical-performance outcome. The authors excluded conference articles, non-English studies, animal work, and studies that did not fit those performance criteria.
That is good methodology for answering the specific question the meta-analysis asked. But it necessarily leaves out parts of the broader sports literature—including some injury-recovery research, conference publications, non-English studies, case reports, longer-term biological outcomes, and other athlete-focused endpoints. H2HUBB’s athlete research file currently catalogs a much broader body of studies across soccer, basketball, track and field, cycling, swimming, judo, resistance exercise, and other exercise models. fileciteturn34file1
So I think the right approach is to use the meta-analysis as one high-level layer of evidence, then look at the individual studies to understand where the signal appears strongest.
Even the 2024 Meta-Analysis Shows More Than the Headline Pooled Results
Explosive Power Improved
The pooled effect on lower-limb explosive power was statistically significant. The authors reported a small overall effect, while the hydrogen-gas subgroup showed a moderate significant effect.
Fatigue Perception Improved
Overall rating of perceived exertion was significantly lower with H2. Subgroup effects were particularly notable during strength training and repeated sprints, where the standardized effects were large.
Lactate Was Significantly Reduced
Blood lactate was significantly lower overall, and the hydrogen-rich-water subgroup was also significant. The aerobic-endurance subgroup showed a significant reduction as well.
A Separate Meta-Analysis Found Improved Antioxidant Potential
A second 2024 systematic review and meta-analysis found that H2 significantly improved biological antioxidant potential, with a larger significant effect during intermittent exercise, even though the pooled d-ROM oxidative-stress marker itself did not significantly fall.
That last point is particularly important. Exercise-generated reactive species are not simply “bad.” They also participate in adaptation and cell signaling. A result in which H2 supports antioxidant capacity without indiscriminately suppressing every oxidative marker is biologically different from saying H2 had no effect.
Individual Human Studies Show Context-Specific Benefits
When I look beyond one pooled average and examine the individual trials, I see a much broader and more consistent pattern around anti-fatigue effects, lactate handling, maintenance of muscle function, power output, cardiovascular efficiency, recovery, and protection against excessive exercise stress. H2HUBB’s athlete research compilation tracks these outcomes across sports including soccer, basketball, track and field, cycling, swimming, and judo, with studies using hydrogen water, inhalation, topical hydrogen, baths, and other administration methods. fileciteturn34file1
Lower Lactate and Better Maintenance of Muscle Function
In a double-blind crossover pilot study of 10 elite soccer players, hydrogen-rich water prevented the exercise-associated rise in blood lactate and attenuated the early decline in peak torque during repeated maximal knee extensions.
Endurance and Fatigue Benefits
A randomized double-blind study included 99 non-trained participants and 60 trained participants. Hydrogen water reduced psychometric fatigue after mild exercise, while the trained group showed significantly improved endurance and lower fatigue during moderate exercise.
Lower Heart Rate at the Same Submaximal Workload
In 19 healthy adults, acute hydrogen-water supplementation did not increase maximal VO2, but it significantly lowered average exercising heart rate and respiratory rate. The authors interpreted the lower heart rate at a comparable workload as a potential submaximal aerobic-performance benefit.
Peak Oxygen Uptake Increased With Continued Use
A single dose did not significantly improve peak oxygen uptake, but two weeks of continuous hydrogen-rich-water intake significantly increased VO2peak and tended to increase peak workload during incremental cycling.
Performance Was Better Late in Repeated Sprints
Sixteen professional soccer players completed 15 repeated 30 m sprints. Hydrogen-rich water significantly improved the final-stage sprint times, including approximately 3.4% and 2.7% improvements at 15 m in sprints 14 and 15 and a 1.9% improvement at 30 m in the final sprint.
Faster Movement, Lower Lactate and Less DOMS
In a randomized double-blind crossover study of 12 men, hydrogen-rich water improved lunge performance, reduced blood lactate during and after resistance exercise, and significantly reduced delayed-onset muscle soreness 24 hours later.
Higher Power and Faster Heart-Rate Recovery
After seven days of hydrogen-rich water, 18 dragon boat athletes showed increased maximum and average power during a 30-second rowing test and improved post-exercise heart-rate recovery compared with placebo.
Lower Physical Fatigue and Greater Prefrontal-Cortex Activation
Twenty-four young men inhaled H2 or placebo gas before high-intensity cycling. H2 significantly reduced perceived exertion across workload stages, lowered heart rate at higher workloads, and increased prefrontal-cortex activation at 75% and 100% of maximal workload.
Recovery and Protection From Excessive Exercise Stress Are Part of the Story Too
Performance is not the only outcome that matters to an athlete. The H2 sports literature also includes recovery, muscle soreness, redox status, tissue injury, range of motion, and the ability to maintain performance under repeated stress.
For example, a randomized crossover study found that hydrogen-rich water helped maintain systemic antioxidant potential across three consecutive days of severe exercise, even though the exercise-performance outcomes themselves were not significantly different. A separate randomized study of 36 professional athletes with acute soft-tissue injuries found that adding oral and topical hydrogen to standard treatment accelerated recovery of joint range of motion and improved plasma-viscosity recovery. These are not captured by a narrow statement about whether pooled VO2max or maximal strength changed.
My Current Interpretation of H2 for Exercise
I would phrase this more strongly than the previous version of this article. The exercise literature does not show one universal performance-enhancing effect, but it does show repeated human signals in areas that matter to athletes: fatigue resistance, perceived exertion, lactate handling, preservation of muscle function, explosive power, repeated-sprint performance, submaximal cardiovascular efficiency, heart-rate recovery, antioxidant capacity, muscle soreness, and recovery from strenuous exercise.
Some studies are small. Some endpoints are neutral. Different doses and delivery methods produce different results. Those limitations matter. But I do not think the scientifically fair summary is that hydrogen “may not effectively improve” exercise performance. I think the better summary is that molecular hydrogen has demonstrated ergogenic and recovery-related effects in multiple controlled human studies, with the magnitude and type of benefit depending on the athlete, exercise model, dose, timing, duration, and route of administration.
That distinction is especially relevant to the original TIME article. If the claim being challenged was a vague marketing promise that hydrogen water simply “gives you energy,” then asking for precision was reasonable. But by 2026, we can replace that vague phrase with measurable outcomes that have actually been studied.
What About Inflammation and Oxidative Stress?
This is one of the areas where direct human evidence has become stronger since TIME’s article.
In a randomized, double-blind, placebo-controlled trial published in Scientific Reports, healthy adults consumed 1.5 liters per day of hydrogen water or plain water for four weeks. Some systemic oxidative-stress markers did not differ significantly between groups, which is important to acknowledge. At the same time, the hydrogen-water group showed less apoptosis of peripheral blood mononuclear cells, a decrease in CD14+ cell frequency, and downregulation of transcriptional networks related to inflammatory responses and NF-kB signaling. Antioxidant-capacity effects also differed by age.
That is a better example of how I think hydrogen-water studies should be discussed: report the outcomes that changed and the outcomes that did not.
Why This Matters
TIME’s 2017 article treated antioxidant and anti-inflammatory effects largely as an early possibility. By 2026, there is direct human evidence showing that hydrogen-water protocols can influence specific inflammatory, oxidative-stress, immune, and cell-survival markers. That does not mean every inflammatory disease is proven to respond to hydrogen water, but the biological effects are no longer based only on animal theory.
What About Diabetes, Cardiovascular Disease, Alzheimer’s Disease and Cancer?
This was one of the most important disagreements in my original article. TIME said hydrogen water might theoretically influence conditions linked to oxidative stress and inflammation, but that disease-specific proof had not been established.
The correct 2026 answer is not one blanket statement. The evidence has progressed at different speeds depending on the condition.
As the cross-domain evidence above shows, the broader human H2 literature is already producing measurable signals in multiple systems. The disease-specific question here is therefore narrower: how strong is the evidence for each particular condition, population, outcome, and administration protocol? That is the level at which I think clinical claims should be evaluated.
Direct Clinical Evidence Has Expanded
A 2026 systematic review and meta-analysis included 13 randomized controlled trials and 757 participants with overweight, obesity, and associated metabolic disorders. Hydrogen-rich water produced small reductions in total cholesterol and LDL cholesterol. The authors characterized the effects as statistically detectable but clinically modest.
Promising, but Not a Replacement for Standard Care
Hydrogen-water studies now include metabolic syndrome, type 2 diabetes, impaired fasting glucose, hyperuricemia, fatty-liver populations, and lipid-related outcomes. These studies support continued investigation, not a claim that HRW is an established lipid-lowering or diabetes therapy.
Mechanistic and Preclinical Evidence Remains Important
Molecular-hydrogen research continues to examine oxidative stress, neuroinflammation, mitochondrial function, and amyloid-related pathways. But I would not present hydrogen water as a proven Alzheimer’s treatment based on the current evidence.
Therapeutic Potential, Not Established Treatment
Hydrogen research in cancer includes substantial preclinical work and investigation of supportive or adjunctive roles. A 2024 review described potential and challenges, but the evidence is not sufficient to tell consumers that drinking hydrogen water treats cancer.
What I Would Say Differently Than I Did in 2020
I still think TIME’s wording could have better communicated the therapeutic potential already visible in the research. But I would no longer answer that by implying the existence of a disease model automatically means hydrogen water has been clinically validated for that disease.
In 2026, I would separate the evidence into three levels: direct human hydrogen-water evidence, broader human molecular-hydrogen evidence, and preclinical/mechanistic evidence. That tells readers much more than either “the studies haven’t been conducted” or “hydrogen has benefits in virtually every disease model.”
TIME Claim #2: Do We Know Anything About Hydrogen-Water Dosing?
The article quoted the view that “We don’t know anything about dosing” or how frequently hydrogen water should be consumed for health benefits.
I agreed in 2020 that disease-specific dosing was still under investigation. I still agree with that in 2026. What I would change is the idea that we know nothing about exposure.
Human trials now routinely report water volume, H2 concentration, timing, duration, and in many cases estimated milligrams of H2 per day. A 2026 meta-analysis of randomized hydrogen-water trials in metabolic populations reported protocols ranging from approximately 500–2,000 mL/day, concentrations around 0.5–7.5 mg/L, and estimated daily H2 doses from roughly 3 mg/day to more than 12 mg/day. The review noted that most included trials delivered between about 1 and 7.5 mg/day, with a smaller number using higher-dose protocols.
That does not establish one optimal dose. It tells us something different and useful: the field is now quantifying dose well enough to compare protocols and investigate dose-response relationships.
| Question | 2026 Answer |
|---|---|
| Can we calculate how much H2 is in a serving? | Yes. H2 dose = concentration in mg/L × water volume in liters. |
| Do human trials report meaningful exposure ranges? | Yes. Many modern trials report concentration, serving volume, frequency, and/or estimated mg H2 per day. |
| Is there one universally accepted daily H2 dose for everyone? | No. Population, condition, timing, exposure pattern, concentration, and study design vary substantially. |
| Has a disease-specific dose been established for every condition? | No. Dose-response research remains an important part of the field. |
How H2HUBB Uses Dose in Product Standards
H2HUBB does not present its product-performance threshold as a medical prescription. We use dose to answer a different question: Can the product deliver an amount of dissolved H2 that is practically relevant to the ranges appearing in the human literature?
For portable hydrogen-water generators, our current minimum standard requires at least 0.8 mg of H2 within a practical daily serving pattern not exceeding one liter of water. Other water categories are generally designed so consumers can obtain approximately 1–3 mg H2/day within practical drinking volumes. H2HUBB also evaluates concentration, total volume, repeatability, contamination, cycle time, and category-specific function.
I would not state in 2026 that every person should simply aim for “1–15 mg/day,” as my original article did. The literature now includes both lower-dose and substantially higher-dose protocols, and the relevant dose may depend on the research question.
TIME Claim #3: Does Hydrogen-Water Packaging Matter?
On this point, I think TIME and Dr. Nicholas Perricone were directionally correct.
Molecular hydrogen is a very small gas molecule. Once hydrogen-rich water is exposed to air—or stored in packaging that does not retain H2 well—the dissolved gas can decline over time. That means a label claiming a high hydrogen concentration at production is not enough if the consumer receives a product that has lost most of its H2 before opening it.
H2HUBB’s Current Ready-to-Drink Standard
For prepackaged hydrogen water, H2HUBB currently requires adequate H2-retaining packaging, such as an aluminum can, at least 0.4 mg H2 per container, and a practical path to approximately 0.8–1 mg H2/day within two containers or fewer.
For freshly generated hydrogen water from a bottle, pitcher, tablet, or machine, the practical rule is simpler: prepare it properly and drink it reasonably soon after generation.
So this is an example where revisiting the original TIME article makes me say plainly: this concern was valid.
What I Would Change in My Own 2020 Rebuttal
I think updating an old article should include updating myself, not only updating the source I originally criticized.
I Treated the Broader H2 Literature as a Strong Rebuttal to a Hydrogen-Water Claim
Inhalation and other delivery methods helped show the wider biological relevance of molecular hydrogen, but they should not be used as if they are direct proof of hydrogen-water outcomes.
I Lead With Delivery-Specific Evidence
If the question is hydrogen water, I first look for hydrogen-water RCTs, systematic reviews, dose data, and direct clinical outcomes. Broader H2 evidence comes second as context.
I Used Broad Therapeutic-Potential Language
The wording could make it sound as if the existence of research across many organs and disease models meant comparable evidence strength across all of them.
I Separate Evidence Strength
Human clinical evidence, human mechanistic evidence, animal studies, cell studies, and reviews each answer different questions. They should not be blended into one evidence category.
I Suggested a Broad 1–15 mg/day Target
That range reflected doses appearing in early literature, but it read too much like a general recommendation.
I Distinguish Research Dose From Product Qualification
Human protocols now span a wide range. H2HUBB standards establish practical minimum product performance; they are not medical dosing instructions.
So, Is Hydrogen Water Actually Good for You?
My current answer is that hydrogen-rich water is a research-supported molecular-hydrogen delivery method with demonstrated biological effects and therapeutic potential across a growing range of human studies. I think that is a more accurate description than either treating hydrogen water as a cure-all or reducing the field to a wellness fad.
The human evidence now includes randomized controlled trials, crossover trials, systematic reviews, and meta-analyses examining inflammatory signaling, oxidative-stress regulation, metabolic health, blood lipids, hepatic function, oral inflammatory disease, exercise fatigue, lactate, power output, recovery, cardiovascular responses, and other outcomes. Importantly, the positive evidence is not confined to one isolated study, one organ system, or one research group.
To me, that is exactly what therapeutic potential in humans means. It does not mean that H2 has already been established as a standard treatment for every condition in which a positive effect has appeared. It means that controlled human research is repeatedly demonstrating biological and clinically relevant effects that justify continued therapeutic investigation.
That does not mean every endpoint is positive or that every disease claim is established. What it means is that the evidence has to be interpreted at the level of the actual question being asked. A pooled null result for VO2max does not erase significant repeated-sprint, fatigue, lactate, power, or recovery findings. A short trial in one metabolic population does not define the entire metabolic literature. And a lack of a universal dose does not mean dose cannot be measured or that dose-response research does not exist.
From our position at H2HUBB, the most useful 2026 interpretation is therefore positive-evidence-first but evidence-specific: identify what has actually been demonstrated, distinguish direct human evidence from broader mechanistic or preclinical support, report neutral findings where they occur, and then explain what questions still need to be answered.
It Is “What Does It Do, at What Dose, in Which Population, and How Strong Is the Evidence?”
Explore the Evidence or Compare Independently Evaluated Products
If you want to go deeper than summaries, H2HUBB’s Research Library lets you search the molecular-hydrogen literature by condition, evidence type, delivery method, journal, DOI, author, and more. If you are choosing a product, H2HUBB also independently tests and evaluates hydrogen-water systems before marketplace recommendation.
Hydrogen Water: Frequently Asked Questions
Is hydrogen water actually good for you?
Human research supports biological activity and therapeutic potential for hydrogen-rich water in several areas, including inflammatory signaling, exercise-related outcomes, and metabolic health. The evidence is not equally strong for every condition, and hydrogen water should not be described as a proven treatment for all diseases studied in the broader molecular-hydrogen literature.
Is there human research on hydrogen water?
Yes. A 2024 systematic review included 25 human hydrogen-rich-water publications, and additional randomized trials and meta-analyses have been published since then. H2HUBB’s broader research library also separates human, animal, laboratory, and review evidence so they are not treated as equivalent.
Does hydrogen water reduce inflammation?
Human randomized research has reported changes in inflammatory signaling and immune-related markers after hydrogen-water intake, including downregulation of inflammatory transcriptional networks in a four-week trial of healthy adults. That does not establish hydrogen water as a treatment for every inflammatory condition.
Does hydrogen water improve exercise performance?
Human studies show benefits in several specific exercise outcomes rather than one universal effect. A 2024 meta-analysis found significant improvements in lower-limb explosive power, perceived exertion, and blood lactate, while individual randomized studies have reported improved endurance, VO2peak after continued use, repeated-sprint performance, power output, muscle function, heart-rate recovery, and delayed-onset muscle soreness. Other studies and pooled endpoints are neutral, so the response appears to depend on dose, timing, route, training status, and the exercise being measured.
How much hydrogen should be in hydrogen water?
There is no single universally accepted disease-specific daily dose. Modern trials use a wide range of concentrations and daily H2 exposures. H2HUBB’s product standards focus on whether a device can deliver a practical minimum amount of H2 within realistic drinking volumes; those standards are product-qualification criteria, not medical prescriptions.
Does hydrogen water lose hydrogen after it is made?
Yes. Dissolved H2 can dissipate, especially after opening, exposure to air, or storage in packaging that does not retain hydrogen well. Packaging, storage, and how quickly freshly generated hydrogen water is consumed can therefore affect the actual dose.
Was the TIME article wrong about hydrogen water?
I think TIME was right to challenge specific commercial claims that went beyond the evidence, but its overall portrayal of the research was too shallow even in 2017. Peer-reviewed reviews had already described molecular hydrogen as an emerging medical gas, documented increasing clinical trials and human findings, and treated hydrogen-rich water as a practical administration route. The scientifically balanced position at the time was that the evidence was promising and therapeutically relevant while larger trials, clearer mechanisms, and better dosing research were still needed.
References & Current Resources
- Park A. Is Hydrogen Water Actually Good For You? TIME. August 21, 2017.
- Ichihara M, et al. Beneficial biological effects and the underlying mechanisms of molecular hydrogen — comprehensive review of 321 original articles. Medical Gas Research. 2015.
- Ostojic SM. Molecular hydrogen: An inert gas turns clinically effective. Annals of Medicine. 2015.
- Nakao A. The Clinical Application of Hydrogen as a Medical Treatment. Acta Medica Okayama. 2016.
- Molecular Hydrogen Institute. Tyler W. LeBaron — documented scientific and medical presentations, 2015–2017.
- Dhillon G, et al. Hydrogen Water: Extra Healthy or a Hoax?—A Systematic Review. Int J Mol Sci. 2024.
- Zhou K, et al. Can molecular hydrogen supplementation enhance physical performance in healthy adults? A systematic review and meta-analysis. Front Nutr. 2024.
- Li Y, et al. Can molecular hydrogen supplementation reduce exercise-induced oxidative stress in healthy adults? A systematic review and meta-analysis. Front Nutr. 2024.
- Aoki K, et al. Effects of drinking hydrogen-rich water on muscle fatigue caused by acute exercise in elite athletes. Med Gas Res. 2012.
- Mikami T, et al. Drinking hydrogen water enhances endurance and relieves psychometric fatigue. Can J Physiol Pharmacol. 2019.
- LeBaron TW, et al. Acute supplementation with molecular hydrogen benefits submaximal exercise indices. J Lifestyle Med. 2019.
- Hori A, et al. Two-week continuous supplementation of hydrogen-rich water increases peak oxygen uptake during incremental cycling. Med Gas Res. 2020.
- Botek M, et al. Molecular Hydrogen Mitigates Performance Decrement during Repeated Sprints in Professional Soccer Players. Nutrients. 2022.
- Botek M, et al. Hydrogen Rich Water Consumption Positively Affects Muscle Performance, Lactate Response, and DOMS After Resistance Training. J Strength Cond Res. 2022.
- Dong G, et al. Short-Term Consumption of Hydrogen-Rich Water Enhances Power Performance and Heart Rate Recovery in Dragon Boat Athletes. 2022.
- Hong Y, et al. Effects of pre-exercise H2 inhalation on physical fatigue and prefrontal cortex activation. Front Physiol. 2022.
- Dobashi S, et al. Hydrogen-rich water suppresses the reduction in blood total antioxidant capacity induced by 3 consecutive days of severe exercise. Med Gas Res. 2020.
- Ostojic SM, et al. Effectiveness of oral and topical hydrogen for sports-related soft tissue injuries. Postgrad Med. 2014.
- Todorovic N, et al. The Effects of Hydrogen-Rich Water on Blood Lipid Profiles in Clinical Populations: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2023.
- Todorovic N, Ostojic SM. Dihydrogen and Hepatic Function: Systematic Review and Meta-analysis. 2024.
- Bai et al. Effects of hydrogen rich water and pure water on periodontal inflammatory factors, oxidative stress and oral flora: systematic review and meta-analysis.
- Sim M, et al. Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults. Sci Rep. 2020.
- The effect of hydrogen-rich water interventions on lipid profiles in adults with overweight or obesity and associated metabolic disorders. Diabetol Metab Syndr. 2026.
- The Therapeutic Application of Hydrogen in Cancer: The Potential and Challenges. Curr Pharm Des. 2024.
- H2HUBB Molecular Hydrogen Research Library
- H2HUBB Product Performance Standards